These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22766701)

  • 1. Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease.
    Mao X; Ait-Aissa K; Lagrange J; Youcef G; Louis H
    Biomed Mater Eng; 2012; 22(1-3):35-48. PubMed ID: 22766701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostasis alterations in metabolic syndrome (review).
    Palomo I; Alarcón M; Moore-Carrasco R; Argilés JM
    Int J Mol Med; 2006 Nov; 18(5):969-74. PubMed ID: 17016629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms for vascular injury in the metabolic syndrome.
    Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T
    Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
    Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
    Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome and cardiovascular disease.
    Bonora E
    Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A central role of eNOS in the protective effect of wine against metabolic syndrome.
    Leighton F; Miranda-Rottmann S; Urquiaga I
    Cell Biochem Funct; 2006; 24(4):291-8. PubMed ID: 16170835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome, insulin resistance and cardiovascular disease.
    Ascott-Evans BH
    SADJ; 2005 Apr; 60(3):122, 127. PubMed ID: 15901021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Lin JM; Yue XJ; Cheng KK; Liu B; Jin YL; Zhang WS; Thomas GN;
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):181-8. PubMed ID: 20039893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome.
    Otani H
    Antioxid Redox Signal; 2011 Oct; 15(7):1911-26. PubMed ID: 21126197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercoagulability in the metabolic syndrome.
    Nieuwdorp M; Stroes ES; Meijers JC; Büller H
    Curr Opin Pharmacol; 2005 Apr; 5(2):155-9. PubMed ID: 15780824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and significance of progenitor cell reduction in the metabolic syndrome.
    Fadini GP; Agostini C; Boscaro E; Avogaro A
    Metab Syndr Relat Disord; 2009 Feb; 7(1):5-10. PubMed ID: 19183074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
    Gaspard U
    Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.